Abstract: The lupus erythematosus autoimmune disease is connected with a broad variety of cutaneous pathology. Cutaneous symptoms are often the presenting indication of lupus erythematosus (LE), and in the case of particular cutaneous lupus erythematosus (CLE) subtypes, they can happen in the lack of systemic disease. This review aimed to focus on the management and treatment of dermatological manifestation of cutaneous lupus erythematosus (CLE), also to evaluate the diagnostic procedures of CLE and to discuss the subtypes of CLE. Electronic databases (PubMed/ Embase) were searched up to December, 2016, for relevant literature in the treatment of cutaneous lupus erythematosus (CLE), we retracted most evidence based review, trails, and randomized control studies discussing the CLE management, furthermore we searched references column of each identified study for more relevant articles that did not show up by previous search method. English language restriction for published studies was applied. The management of CLE consists of regular evaluation for systemic disease, also prevention of new sores and treatment of existing sores. Avoidance is accomplished by ideal defense against UV direct exposure, with broad-spectrum sunscreen as a reliable method of preventing development of UV-induced CLE. Treatment includes topical and systemic options. There is good proof to support using topical steroids and topical calcineurin inhibitors.
Keywords: cutaneous lupus erythematosus (CLE), cutaneous pathology, systemic disease.
Title: Cutaneous Lupus Erythematosus, Dermatological Approaches of Treatment
Author: Hind Sajdi T Al Atawi, Alshaymaa Abdulrahman AlShaikh, Abdulghani, Fahad Majdy M, Jabir Abdulrahman K Alzaidi, ALBaqami,Haya Majed M
International Journal of Healthcare Sciences
ISSN 2348-5728 (Online)
Research Publish Journals
